70 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6817

Winston Medical Supply
NT$92.00-1.1%3.1%NT$1.7bn/aPE11.3xn/a7.2%

4102

Yung Zip Chemical Ind
NT$40.053.6%3.9%NT$1.7bn/aPE18.4xn/a2.0%

6562

UBI Pharma
NT$14.251.8%-62.3%NT$1.7bn/aPE2097.4xn/a0%

1780

Allied Biotech
NT$17.100%-3.9%NT$1.6bn/aPE15.5xn/a5.0%

4127

Tien Liang BioTech
NT$34.75-3.9%158.4%NT$1.6bn/aPE161.4xn/a1.4%

7427

Great Novel Therapeutics Biotech & Medicals
NT$36.002.9%-55.1%NT$1.6bn/aPS2551.4xn/an/a

6645

Kim Forest Enterprise
NT$28.751.4%-35.4%NT$1.5bn/aPS3.4xn/a0.3%

4111

Chi Sheng Pharma & Biotech
NT$26.250%1.7%NT$1.5bn/aPE20.5xn/a3.8%

4186

Taiwan Advance Bio-Pharmaceutical
NT$15.90-3.6%-9.7%NT$1.4bn/aPE66.9xn/an/a

6539

DV Biomed
NT$68.10-0.9%-61.5%NT$1.4bn/aPE26.7xn/a2.9%

4195

Genomics BioSci & Tech.Ltd
NT$18.10-0.8%-13.2%NT$1.3bn/aPS3.1xn/a0%

6814

Lukas Biomedical
NT$30.202.7%-1.1%NT$1.3bn/aPS5.9xn/an/a

4131

NeoCore Technology
NT$31.901.3%41.8%NT$1.3bn/aPS19.2xn/an/a

6652

Eusol BiotechLtd
NT$8.000.3%-20.4%NT$1.1bn/aPB2.8xn/an/a

6483

Original BioMedicals
NT$15.80-1.6%n/aNT$1.0bn/aPS24248.2xn/an/a

6662

BioLASCO Taiwan
NT$36.301.1%11.9%NT$929.7mn/aPE22.3xn/a4.5%

6935

Prince Pharmaceutical
NT$22.151.6%-43.9%NT$810.8mn/aPS1.1xn/a1.1%

7561

Bioray Biotech
NT$23.20-3.9%-28.6%NT$692.1mn/aPS3.8xn/a0%

4170

Vectorite Biomedical
NT$15.000%n/aNT$656.6mn/aPS12.3xn/an/a

6661

Welgene BiotechLtd
NT$24.10-0.4%4.3%NT$561.6mn/aPS1.9xn/a0%

6848

RBC Bioscience
NT$19.50-2.3%30.0%NT$253.0mn/aPE14.7xn/a5.7%

6566

Chuang Yi Biotech
NT$5.200%-65.3%NT$176.5mn/aPB1.3xn/an/a
Page 3 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.